Adults 18 years and older with Type 1 or 2 Diabetes and Gastroparesis
A study to evaluate the safety and efficacy of Relamorelin compared to placebo
RLM-MD-02
Study Length: 12 weeks
Target Age/Sex: 18 years and older, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures
Link: ClinicalTrials.gov